BioNTech SE (BNTX)
USD 104.94
(2.45%)
USD 104.94
(2.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 930.3 Million EUR | -90.14% |
| 2022 | 9.43 Billion EUR | -8.34% |
| 2021 | 10.29 Billion EUR | 67613.82% |
| 2020 | 15.2 Million EUR | 108.48% |
| 2019 | -179.17 Million EUR | -273.13% |
| 2018 | -48.01 Million EUR | 43.94% |
| 2017 | -85.65 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -811.88 Million EUR | -156.36% |
| 2024 Q1 | -315.1 Million EUR | -168.81% |
| 2023 Q4 | 457.9 Million EUR | 185.12% |
| 2023 FY | 930.3 Million EUR | -90.14% |
| 2023 Q3 | 160.6 Million EUR | 184.35% |
| 2023 Q2 | -190.4 Million EUR | -137.91% |
| 2023 Q1 | 502.2 Million EUR | -77.96% |
| 2022 FY | 9.43 Billion EUR | -8.34% |
| 2022 Q3 | 1.78 Billion EUR | 6.75% |
| 2022 Q2 | 1.67 Billion EUR | -54.8% |
| 2022 Q1 | 3.69 Billion EUR | 16.82% |
| 2022 Q4 | 2.27 Billion EUR | 27.67% |
| 2021 Q2 | 2.78 Billion EUR | 147.07% |
| 2021 FY | 10.29 Billion EUR | 67613.82% |
| 2021 Q1 | 1.12 Billion EUR | 207.46% |
| 2021 Q4 | 3.16 Billion EUR | -1.4% |
| 2021 Q3 | 3.21 Billion EUR | 15.21% |
| 2020 FY | 15.2 Million EUR | 108.48% |
| 2020 Q4 | 366.91 Million EUR | 274.69% |
| 2020 Q3 | -210.03 Million EUR | -137.87% |
| 2020 Q1 | -53.38 Million EUR | 8.31% |
| 2020 Q2 | -88.29 Million EUR | -65.39% |
| 2019 Q3 | -30.1 Million EUR | 39.89% |
| 2019 Q2 | -50.08 Million EUR | -23.22% |
| 2019 Q1 | -40.64 Million EUR | -2906.36% |
| 2019 FY | -179.17 Million EUR | -273.13% |
| 2019 Q4 | -58.22 Million EUR | -93.41% |
| 2018 Q1 | -11.61 Million EUR | 0.0% |
| 2018 Q4 | -1.35 Million EUR | 94.23% |
| 2018 FY | -48.01 Million EUR | 43.94% |
| 2018 Q3 | -23.43 Million EUR | -101.7% |
| 2018 Q2 | -11.61 Million EUR | 0.0% |
| 2017 FY | -85.65 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Absci Corporation | -110.56 Million USD | 941.398% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 513.008% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 311.316% |
| Alzamend Neuro, Inc. | -9.94 Million USD | 9451.867% |
| Apollomics, Inc. | -172.6 Million USD | 638.989% |
| 180 Life Sciences Corp. | -19.93 Million USD | 4766.64% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | 3191.314% |
| Bicycle Therapeutics plc | -180.66 Million USD | 614.934% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | 1368.355% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 619.567% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | 3553.486% |
| Chimerix, Inc. | -82.09 Million USD | 1233.199% |
| CRISPR Therapeutics AG | -153.61 Million USD | 705.625% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | -3994.63% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | 1414.076% |
| Fortress Biotech, Inc. | -60.63 Million USD | 1634.212% |
| Fortress Biotech, Inc. | -60.63 Million USD | 1634.212% |
| Gritstone bio, Inc. | -138.49 Million USD | 771.745% |
| Allakos Inc. | -185.7 Million USD | 600.967% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | 1981.903% |
| Cara Therapeutics, Inc. | -118.51 Million USD | 884.977% |
| Cytokinetics, Incorporated | -526.24 Million USD | 276.781% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | 1031.073% |
| Innoviva, Inc. | 179.72 Million USD | -417.633% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | 11957.919% |
| NLS Pharmaceutics AG | -12.17 Million USD | 7742.933% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | 896.503% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | 7417169.225% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | 1131.26% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | 1225.753% |
| ImmuCell Corporation | -5.77 Million USD | 16210.212% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | 923.559% |
| Incyte Corporation | 597.59 Million USD | -55.673% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | 788.513% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 14058.201% |
| Mustang Bio, Inc. | -51.6 Million USD | 1902.837% |
| MiMedx Group, Inc. | 67.43 Million USD | -1279.469% |
| MEI Pharma, Inc. | 17.77 Million USD | -5132.872% |
| MacroGenics, Inc. | -9.05 Million USD | 10370.479% |
| Monopar Therapeutics Inc. | -8.4 Million USD | 11172.105% |
| Mereo BioPharma Group plc | -29.46 Million USD | 3257.198% |
| Marker Therapeutics, Inc. | -14.04 Million USD | 6723.287% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 757.898% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | 881.574% |
| Minerva Neurosciences, Inc. | -30 Million USD | 3200.447% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | 7560.305% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | 9304.512% |
| NextCure, Inc. | -62.72 Million USD | 1583.188% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | 1993.933% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | 9416.042% |
| Onconetix, Inc. | -37.4 Million USD | 2586.789% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | 2456.443% |
| Opthea Limited | -220.24 Million USD | 522.399% |
| Ovid Therapeutics Inc. | -52.33 Million USD | 1877.452% |
| Psyence Biomedical Ltd. | -51.15 Million USD | 1918.447% |
| PDS Biotechnology Corporation | -42.94 Million USD | 2266.401% |
| Precigen, Inc. | -95.9 Million USD | 1070.033% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | 3890.49% |
| Prime Medicine, Inc. | -198.13 Million USD | 569.533% |
| PureTech Health plc | -65.69 Million USD | 1516.046% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 478.794% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 76.47% |
| Replimune Group, Inc. | -215.79 Million USD | 531.106% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 773712.52% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | 3807.704% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | 5116.15% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 313.192% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 3922.215% |
| Sesen Bio, Inc. | -19.88 Million USD | 4778.636% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 460.818% |
| Solid Biosciences Inc. | -96.01 Million USD | 1068.911% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 544.354% |
| SciSparc Ltd. | -5.12 Million USD | 18262.827% |
| Sutro Biopharma, Inc. | -106.79 Million USD | 971.125% |
| TG Therapeutics, Inc. | 12.67 Million USD | -7241.383% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | 897.459% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | 16804.974% |
| Travere Therapeutics, Inc. | -111.39 Million USD | 935.106% |
| UroGen Pharma Ltd. | -102.24 Million USD | 1009.882% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | 1488.611% |
| XOMA Corporation | -40.83 Million USD | 2378.416% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 418.388% |
| AbCellera Biologics Inc. | -146.39 Million USD | 735.46% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | 1809.419% |
| Cassava Sciences, Inc. | -97.21 Million USD | 1056.931% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | 2185.719% |
| Precision BioSciences, Inc. | -61.31 Million USD | 1617.148% |
| Dyadic International, Inc. | -6.79 Million USD | 13790.02% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | 8928.051% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | 99491.026% |
| VYNE Therapeutics Inc. | -28.45 Million USD | 3369.717% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | 849.734% |
| IGM Biosciences, Inc. | -246.41 Million USD | 477.532% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | 1019.569% |
| Acelyrin, Inc. | -381.64 Million USD | 343.763% |
| Abeona Therapeutics Inc. | -54.18 Million USD | 1816.801% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | -1683.756% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | 4988.884% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | 3229.689% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 665.278% |
| Senti Biosciences, Inc. | -92.91 Million USD | 1101.195% |
| Mesoblast Limited | -87.95 Million USD | 1157.688% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 733.021% |
| ChromaDex Corporation | -4.93 Million USD | 18939.611% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 19515.77% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | 1891.623% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | 12035.048% |
| Seer, Inc. | -86.27 Million USD | 1178.271% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | 1594.338% |
| Novavax, Inc. | -545.06 Million USD | 270.678% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | 6224.622% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 678.085% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | 1894.318% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 496.493% |
| Celcuity Inc. | -63.77 Million USD | 1558.628% |
| ContextLogic Inc. | -317 Million USD | 393.47% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 561.477% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | 1240.353% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | -124.259% |
| Amarin Corporation plc | -59.11 Million USD | 1673.792% |
| AnaptysBio, Inc. | -163.61 Million USD | 668.577% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | 5443.174% |
| Aptorum Group Limited | -2.82 Million USD | 33035.089% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 523.422% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 553.197% |
| Ardelyx, Inc. | -66.06 Million USD | 1508.116% |
| Celularity Inc. | -196.29 Million USD | 573.93% |
| Omeros Corporation | -117.81 Million USD | 889.641% |
| Humacyte, Inc. | -110.77 Million USD | 939.803% |
| Immunocore Holdings plc | -55.28 Million USD | 1782.674% |
| IO Biotech, Inc. | -86.08 Million USD | 1180.701% |
| GT Biopharma, Inc. | -7.59 Million USD | 12345.623% |
| Cabaletta Bio, Inc. | -67.67 Million USD | 1474.658% |
| Summit Therapeutics Inc. | -614.92 Million USD | 251.286% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | 2747.41% |
| Pulmatrix, Inc. | -14.12 Million USD | 6688.06% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 293.332% |
| Evogene Ltd. | -23.87 Million USD | 3995.892% |
| CorMedix Inc. | -46.33 Million USD | 2107.586% |
| BioLineRx Ltd. | -60.61 Million USD | 1634.794% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | 3268.381% |
| Sagimet Biosciences Inc. | -27.87 Million USD | 3437.279% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 248.467% |
| scPharmaceuticals Inc. | -54.81 Million USD | 1797.318% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | 1055.771% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | -776.484% |
| NLS Pharmaceutics AG | -12.17 Million USD | 7742.933% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 3922.215% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 713.011% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | 2748.993% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | 4564.012% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | 988.547% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | 1302.124% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | 1677.243% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | 5414.135% |
| Daré Bioscience, Inc. | -30.16 Million USD | 3184.407% |
| bluebird bio, Inc. | -211.91 Million USD | 539.001% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | -454.923% |
| DBV Technologies S.A. | -72.72 Million USD | 1379.185% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 538.366% |
| Galecto, Inc. | -38.34 Million USD | 2525.878% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | 2828.072% |
| Spruce Biosciences, Inc. | -47.91 Million USD | 2041.401% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 485.439% |
| GlycoMimetics, Inc. | -36.89 Million USD | 2621.178% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 454.887% |
| ADMA Biologics, Inc. | -28.23 Million USD | 3394.38% |
| Clene Inc. | -49.5 Million USD | 1979.242% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 383.571% |
| Aptose Biosciences Inc. | -51.2 Million USD | 1916.744% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | 1046.408% |
| Soligenix, Inc. | -6.14 Million USD | 15249.665% |
| Century Therapeutics, Inc. | -136.67 Million USD | 780.676% |
| Kura Oncology, Inc. | -152.63 Million USD | 709.509% |
| Surrozen, Inc. | -43.04 Million USD | 2261.377% |
| TScan Therapeutics, Inc. | -89.21 Million USD | 1142.727% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | -164418.012% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | 163597.364% |
| Autolus Therapeutics plc | -208.38 Million USD | 546.438% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | 1393.916% |
| Eterna Therapeutics Inc. | -21.66 Million USD | 4393.428% |
| Caribou Biosciences, Inc. | -102.07 Million USD | 1011.433% |
| GRI Bio, Inc. | -13.03 Million USD | 7235.844% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | 22600.483% |
| Janux Therapeutics, Inc. | -58.29 Million USD | 1695.903% |
| INmune Bio, Inc. | -30 Million USD | 3200.173% |
| Heron Therapeutics, Inc. | -110.55 Million USD | 941.451% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 2304.827% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 5928.342% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | 12165.095% |
| Jaguar Health, Inc. | -41.3 Million USD | 2352.542% |
| Entero Therapeutics, Inc. | -15.79 Million USD | 5989.845% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | 1658.683% |
| Clearside Biomedical, Inc. | -32.48 Million USD | 2963.783% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 436.911% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 491.06% |
| Verastem, Inc. | -87.36 Million USD | 1164.819% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 676.623% |
| Histogen Inc. | -10.62 Million USD | 8859.062% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | 6611.625% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | 1617.965% |
| Surrozen, Inc. | -43.04 Million USD | 2261.377% |
| Organovo Holdings, Inc. | -14.67 Million USD | 6441.081% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 18387.688% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | 11231.871% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 715.746% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | 2001.441% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | 9029.991% |
| Kronos Bio, Inc. | -112.67 Million USD | 925.664% |
| Turnstone Biologics Corp. | -55.2 Million USD | 1785.326% |
| Synaptogenix, Inc. | -6.03 Million USD | 15506.134% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | 5839.758% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | 14016.23% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | 1292.387% |
| Exelixis, Inc. | 207.76 Million USD | -347.766% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 746.275% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 275.984% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 1543.109% |
| ESSA Pharma Inc. | -26.58 Million USD | 3599.692% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 23357.791% |
| Avid Bioservices, Inc. | -140.75 Million USD | 760.945% |
| Insmed Incorporated | -749.56 Million USD | 224.112% |
| MediWound Ltd. | -6.71 Million USD | 13951.995% |
| OmniAb, Inc. | -50.61 Million USD | 1937.847% |
| Alector, Inc. | -130.39 Million USD | 813.469% |
| Seres Therapeutics, Inc. | -113.72 Million USD | 918.033% |
| Zai Lab Limited | -334.62 Million USD | 378.017% |
| AlloVir, Inc. | -190.41 Million USD | 588.557% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 387.142% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | 1023.861% |
| Aura Biosciences, Inc. | -76.4 Million USD | 1317.543% |
| Immunic, Inc. | -93.61 Million USD | 1093.783% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | 784.583% |
| Veracyte, Inc. | -74.4 Million USD | 1350.336% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | 12220.304% |
| FibroGen, Inc. | -284.23 Million USD | 427.303% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 3646.432% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | -1202.759% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 13386.413% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | 5039.814% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | 4224.584% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | -1788.129% |
| Fortrea Holdings Inc. | -3.4 Million USD | 27461.765% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | 834.579% |
| XBiotech Inc. | -24.55 Million USD | 3888.329% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 1543.109% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 708.071% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | 2591.43% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | 1584.205% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | 1045.177% |
| Agenus Inc. | -245.76 Million USD | 478.538% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | 4441.718% |
| Theravance Biopharma, Inc. | -55.19 Million USD | 1785.54% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 253.353% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | 1462.977% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 510.658% |
| Gain Therapeutics, Inc. | -22.26 Million USD | 4277.834% |
| C4 Therapeutics, Inc. | -132.49 Million USD | 802.15% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | 17697.408% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | 3940.882% |
| Lantern Pharma Inc. | -15.96 Million USD | 5928.387% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | 2406.948% |
| Ainos, Inc. | -13.77 Million USD | 6855.722% |
| Pluri Inc. | -20.88 Million USD | 4553.753% |
| Prothena Corporation plc | -147.02 Million USD | 732.737% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | 916.977% |
| Rallybio Corporation | -74.56 Million USD | 1347.653% |
| Kodiak Sciences Inc. | -260.49 Million USD | 457.133% |
| Cue Biopharma, Inc. | -50.73 Million USD | 1933.718% |
| MeiraGTx Holdings plc | -84.02 Million USD | 1207.144% |
| Annexon, Inc. | -134.23 Million USD | 793.028% |
| Assembly Biosciences, Inc. | -61.22 Million USD | 1619.403% |
| Moderna, Inc. | -4.71 Billion USD | 119.735% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | 5272.931% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | 4156.953% |
| Blueprint Medicines Corporation | -506.98 Million USD | 283.497% |
| Immix Biopharma, Inc. | -15.42 Million USD | 6130.709% |
| CalciMedica, Inc. | -34.35 Million USD | 2807.745% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | 787.319% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 661.135% |
| Wave Life Sciences Ltd. | -57.51 Million USD | 1717.547% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 428.432% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | 2743.273% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | 987.09% |
| Nutriband Inc. | -5.48 Million USD | 17059.831% |
| Protara Therapeutics, Inc. | -40.42 Million USD | 2401.583% |
| Vor Biopharma Inc. | -117.86 Million USD | 889.306% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 78.609% |
| Alkermes plc | 355.75 Million USD | -161.499% |
| ProKidney Corp. | -35.46 Million USD | 2722.928% |
| Applied Therapeutics, Inc. | -119.76 Million USD | 876.784% |
| Arcellx, Inc. | -70.69 Million USD | 1416.028% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 244.636% |
| Tango Therapeutics, Inc. | -101.74 Million USD | 1014.354% |
| Galectin Therapeutics Inc. | -41.06 Million USD | 2365.378% |
| Atai Life Sciences N.V. | -40.22 Million USD | 2412.798% |
| Renovaro Biosciences Inc. | -80.65 Million USD | 1253.5% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | 1331.843% |
| MediciNova, Inc. | -8.57 Million USD | 10953.389% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | 854.642% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 11205.628% |
| GeoVax Labs, Inc. | -25.96 Million USD | 3682.657% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 488.86% |
| Biomea Fusion, Inc. | -117.25 Million USD | 893.399% |
| RenovoRx, Inc. | -10.23 Million USD | 9192.064% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 707.396% |
| Geron Corporation | -184.12 Million USD | 605.249% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 3185.572% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | 1022.578% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 494.3% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | -6505.368% |
| Royalty Pharma plc | 1.13 Billion USD | 18.023% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 582.116% |
| Imunon, Inc. | -19.51 Million USD | 4867.108% |
| BioAtla, Inc. | -123.46 Million USD | 853.511% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 384.265% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | 2617.795% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 641.912% |
| Structure Therapeutics Inc. | -89.62 Million USD | 1138.05% |
| 89bio, Inc. | -142.18 Million USD | 754.27% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | 1013.223% |
| aTyr Pharma, Inc. | -50.38 Million USD | 1946.236% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | 1161.029% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 491.32% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | 11596.625% |
| Akari Therapeutics, Plc | -10 Million USD | 9395.564% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 1381904.679% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | -230.369% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 625.24% |
| Liquidia Corporation | -78.5 Million USD | 1285.065% |
| Entera Bio Ltd. | -8.88 Million USD | 10565.744% |
| GH Research PLC | -35.58 Million USD | 2714.157% |
| Vericel Corporation | -3.18 Million USD | 29336.329% |
| Arbutus Biopharma Corporation | -72.84 Million USD | 1377.025% |
| Xencor, Inc. | -126.08 Million USD | 837.824% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | 24804.557% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 5928.342% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | 4474.478% |
| Vaxcyte, Inc. | -402.26 Million USD | 331.265% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 610.052% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | -36978.517% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 14058.201% |
| Portage Biotech Inc. | -75.33 Million USD | 1334.819% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 11205.628% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | 1062.495% |
| OncoCyte Corporation | -27.78 Million USD | 3448.692% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | 7033.631% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | 8464.864% |
| Purple Biotech Ltd. | -19.88 Million USD | 4779.577% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | 3254.522% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | 3515.449% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 603.742% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | 13354.025% |
| Moleculin Biotech, Inc. | -29.76 Million USD | 3225.063% |
| United Therapeutics Corporation | 984.8 Million USD | 5.534% |
| HilleVax, Inc. | -123.56 Million USD | 852.877% |
| Silo Pharma, Inc. | -3.7 Million USD | 25238.603% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | 7216.812% |
| Pharming Group N.V. | -10.54 Million USD | 8919.681% |
| Tharimmune, Inc. | -9.31 Million USD | 10082.73% |
| Genprex, Inc. | -30.86 Million USD | 3114.537% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 1207.698% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 494.32% |
| Pyxis Oncology, Inc. | -73.79 Million USD | 1360.74% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | 52305.387% |
| Virios Therapeutics, Inc. | -5.29 Million USD | 17666.038% |
| OKYO Pharma Limited | -16.82 Thousand USD | 5529220.749% |
| Savara Inc. | -54.69 Million USD | 1800.793% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 4684.791% |
| Curis, Inc. | -47.41 Million USD | 2062.12% |
| Carmell Therapeutics Corporation | -15.44 Million USD | 6123.275% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | 3220.241% |
| BeiGene, Ltd. | -881.7 Million USD | 205.511% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | 1278.266% |
| Erasca, Inc. | -125.04 Million USD | 843.99% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 18704.151% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 18704.151% |
| Vincerx Pharma, Inc. | -40.15 Million USD | 2416.657% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | 16438.251% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | 1640.538% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 757.786% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 583.499% |
| Adicet Bio, Inc. | -142.65 Million USD | 752.119% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 713.719% |
| Aditxt, Inc. | -32.38 Million USD | 2972.995% |
| Adagene Inc. | -18.94 Million USD | 5010.175% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 12823.403% |
| Quantum-Si incorporated | -95.96 Million USD | 1069.466% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 6481.635% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | -603.015% |
| Compugen Ltd. | -18.75 Million USD | 5060.542% |
| Generation Bio Co. | -126.61 Million USD | 834.764% |
| Astria Therapeutics, Inc. | -72.89 Million USD | 1376.289% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | 1228.43% |
| Invivyd, Inc. | -198.64 Million USD | 568.328% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 372.039% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | 10809.632% |
| Spero Therapeutics, Inc. | 22.8 Million USD | -3979.19% |
| Artelo Biosciences, Inc. | -9.87 Million USD | 9521.714% |
| 2seventy bio, Inc. | -217.57 Million USD | 527.587% |
| Instil Bio, Inc. | -156.08 Million USD | 696.014% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | 4274.081% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | 21727.254% |
| GeoVax Labs, Inc. | -25.96 Million USD | 3682.657% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | 2958.687% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | 1041.678% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 678.527% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 251.253% |
| Evaxion Biotech A/S | -22.12 Million USD | 4304.746% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | 1252.274% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 564.992% |
| Tyra Biosciences, Inc. | -69.13 Million USD | 1445.648% |
| Cingulate Inc. | -23.53 Million USD | 4052.845% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | 13559.201% |
| Unity Biotechnology, Inc. | -39.86 Million USD | 2433.919% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | 1663.451% |
| Clearmind Medicine Inc. | -11.95 Million USD | 7881.661% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | 1444.422% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 36680527.248% |
| Viking Therapeutics, Inc. | -85.89 Million USD | 1183.067% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 348.99% |
| ImmunityBio, Inc. | -583.19 Million USD | 259.518% |
| Korro Bio, Inc. | -81.17 Million USD | 1246.085% |
| Kineta, Inc. | -14.09 Million USD | 6698.34% |
| BioVie Inc. | -32.12 Million USD | 2996.278% |
| Codexis, Inc. | -76.24 Million USD | 1320.226% |
| Celularity Inc. | -196.29 Million USD | 573.93% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | 6013.425% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 533.648% |
| Virax Biolabs Group Limited | -6.73 Million USD | 13915.919% |
| Cibus, Inc. | -267.62 Million USD | 447.611% |
| IN8bio, Inc. | -30 Million USD | 3200.277% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | 894.008% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | 3049.214% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 353.982% |
| Eyenovia, Inc. | -27.26 Million USD | 3512.555% |
| Puma Biotechnology, Inc. | 21.59 Million USD | -4208.74% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 173987.85% |
| Elevation Oncology, Inc. | -45.7 Million USD | 2135.489% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | 1317.606% |
| Cardiff Oncology, Inc. | -41.44 Million USD | 2344.878% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | 795.208% |
| Regulus Therapeutics Inc. | -30.03 Million USD | 3197.18% |
| Moolec Science SA | -51.78 Million USD | 1896.332% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | 1876.365% |
| LAVA Therapeutics N.V. | -41.97 Million USD | 2316.372% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | 784.265% |
| Compass Therapeutics, Inc. | -42.49 Million USD | 2289.25% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | 10562.445% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | 4479.277% |
| Humacyte, Inc. | -110.77 Million USD | 939.803% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | 1449.043% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | 9065.019% |
| Genelux Corporation | -28.29 Million USD | 3387.628% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | 3300.757% |
| Notable Labs, Ltd. | -11.26 Million USD | 8359.055% |
| Immunovant, Inc. | -259.33 Million USD | 458.724% |
| Quantum-Si incorporated | -95.96 Million USD | 1069.466% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | 4900.062% |
| Vera Therapeutics, Inc. | -95.99 Million USD | 1069.163% |
| Acasti Pharma Inc. | -12.85 Million USD | 7337.999% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | 4242.425% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | 2486.119% |
| PepGen Inc. | -78.62 Million USD | 1283.196% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | 4279.245% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 19515.77% |
| Immuneering Corporation | -53.47 Million USD | 1839.801% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 18387.688% |
| Belite Bio, Inc | -31.63 Million USD | 3041.009% |
| XOMA Corporation | -40.83 Million USD | 2378.416% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | 1811.211% |
| Bionomics Limited | -15.49 Billion USD | 106.005% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 3290.657% |
| uniQure N.V. | -308.47 Million USD | 401.577% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 12823.403% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | 853.707% |
| Forte Biosciences, Inc. | -31.47 Million USD | 3055.585% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | 11442.766% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | 3300.427% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 173987.85% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 3646.432% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | 5743.312% |
| Altimmune, Inc. | -88.44 Million USD | 1151.816% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | 846.324% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 3290.657% |
| Peak Bio, Inc. | -1259.26 USD | 73876821.249% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | 2120.239% |
| Benitec Biopharma Inc. | -21.75 Million USD | 4377.045% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 374.595% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | 1221.465% |
| Zura Bio Limited | -60.36 Million USD | 1641.252% |
| PolyPid Ltd. | -23.86 Million USD | 3998.177% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | 1221.465% |
| argenx SE | -295.05 Million USD | 415.299% |
| Immunome, Inc. | -106.8 Million USD | 971.018% |
| Verona Pharma plc | -54.36 Million USD | 1811.085% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | 1031.073% |
| Shattuck Labs, Inc. | -87.29 Million USD | 1165.66% |
| CervoMed Inc. | -2.17 Million USD | 42933.996% |
| Plus Therapeutics, Inc. | -13.31 Million USD | 7086.332% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | 2235.92% |
| Moolec Science SA | -51.78 Million USD | 1896.332% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | 5380128.488% |
| Design Therapeutics, Inc. | -66.86 Million USD | 1491.373% |
| Leap Therapeutics, Inc. | -81.41 Million USD | 1242.678% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | 2555.784% |
| Achilles Therapeutics plc | -69.66 Million USD | 1435.391% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 36680527.248% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | 2013.922% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | 1306.756% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | 2838.593% |
| MoonLake Immunotherapeutics | -36 Million USD | 2683.646% |
| Tourmaline Bio, Inc. | -42.12 Million USD | 2308.48% |
| Beam Therapeutics Inc. | -132.52 Million USD | 801.97% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 669.287% |
| AEON Biopharma, Inc. | -52.55 Million USD | 1870.112% |
| Aadi Bioscience, Inc. | -65.76 Million USD | 1514.582% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | 1399.592% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | 7534.136% |
| NeurAxis, Inc. | -14.62 Million USD | 6460.294% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 309.51% |
| Lumos Pharma, Inc. | -34.03 Million USD | 2833.443% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | -30819.406% |
| Palisade Bio, Inc. | -12.3 Million USD | 7663.415% |
| Nutriband Inc. | -5.48 Million USD | 17059.831% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | 933.856% |
| Neurogene Inc. | -36.31 Million USD | 2661.61% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 11043.418% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | 1047.864% |
| Athira Pharma, Inc. | -117.67 Million USD | 890.587% |
| HCW Biologics Inc. | -24.99 Million USD | 3822.052% |
| XOMA Corporation | -40.83 Million USD | 2378.416% |
| Nektar Therapeutics | -276.05 Million USD | 436.997% |
| Arvinas, Inc. | -367.3 Million USD | 353.281% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 1381904.679% |
| Merus N.V. | -154.93 Million USD | 700.43% |
| Omega Therapeutics, Inc. | -97.42 Million USD | 1054.859% |
| Quince Therapeutics, Inc. | -31.38 Million USD | 3064.155% |
| Rezolute, Inc. | -68.45 Million USD | 1458.916% |
| Clene Inc. | -49.5 Million USD | 1979.242% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 6131.716% |
| BeyondSpring Inc. | -21.02 Million USD | 4524.522% |
| Synlogic, Inc. | -57.28 Million USD | 1724.07% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | 7916.99% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 8693.202% |
| Peak Bio, Inc. | -1259.26 USD | 73876821.249% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | 2589.563% |
| Krystal Biotech, Inc. | 10.93 Million USD | -8409.879% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 750.109% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 386.155% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | 20240.876% |
| MannKind Corporation | -11.93 Million USD | 7892.763% |
| Ikena Oncology, Inc. | -68.16 Million USD | 1464.757% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | 4526.838% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | 1101.044% |
| Gossamer Bio, Inc. | -179.81 Million USD | 617.359% |
| CohBar, Inc. | -11.96 Million USD | 7877.05% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | 3707.492% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 3185.572% |
| Legend Biotech Corporation | -518.25 Million USD | 279.507% |
| Mural Oncology plc | -207.44 Million USD | 548.452% |
| Disc Medicine, Inc. | -76.42 Million USD | 1317.208% |
| Champions Oncology, Inc. | -7.27 Million USD | 12885.871% |
| REGENXBIO Inc. | -263.49 Million USD | 453.063% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | 8865.604% |
| Anavex Life Sciences Corp. | -47.5 Million USD | 2058.32% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | 2549.222% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | 1028.786% |
| Vaxart, Inc. | -82.46 Million USD | 1228.115% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | -278630.716% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | 2577.991% |
| Cellectis S.A. | -101.05 Million USD | 1020.551% |
| Longeveron Inc. | -21.41 Million USD | 4444.557% |
| Repare Therapeutics Inc. | -93.79 Million USD | 1091.833% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 273.571% |
| Inozyme Pharma, Inc. | -71.16 Million USD | 1407.17% |
| Revolution Medicines, Inc. | -436.36 Million USD | 313.192% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | 14257.662% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | 3118.103% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | 1441.785% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | 1537.156% |
| Anixa Biosciences, Inc. | -9.81 Million USD | 9582.214% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 74.298% |
| Denali Therapeutics Inc. | -145.22 Million USD | 740.597% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 773712.52% |
| Veru Inc. | -93.15 Million USD | 1098.683% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | 3541.859% |
| Cingulate Inc. | -23.53 Million USD | 4052.845% |
| Passage Bio, Inc. | -102.06 Million USD | 1011.505% |
| Context Therapeutics Inc. | -23.96 Million USD | 3982.039% |
| Exicure, Inc. | -16.91 Million USD | 5600.177% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 592.438% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | 2563.457% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | 14396.198% |
| Nuvalent, Inc. | -126.21 Million USD | 837.052% |
| ABVC BioPharma, Inc. | -10.51 Million USD | 8946.809% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | 1170.8% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | 3145.77% |
| OmniAb, Inc. | -50.61 Million USD | 1937.847% |
| Anew Medical, Inc. | 1.34 Million USD | -69009.481% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | 5898.068% |
| Lipocine Inc. | -16.35 Million USD | 5789.184% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | 1501.181% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | 1561.013% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 2304.827% |
| G1 Therapeutics, Inc. | -47.96 Million USD | 2039.458% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | 4791.14% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 271.804% |
| Ocugen, Inc. | -63.07 Million USD | 1574.841% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | 1071.775% |
| Q32 Bio Inc. | -112.96 Million USD | 923.559% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | 5511.238% |
| Alumis Inc. Common Stock | -154.99 Million USD | 700.221% |
| Equillium, Inc. | -13.33 Million USD | 7076.378% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | 1641.099% |
| Coya Therapeutics, Inc. | -7.98 Million USD | 11746.458% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | 5034.958% |
| Dominari Holdings Inc. | -22.88 Million USD | 4165.641% |
| Edesa Biotech, Inc. | -8.37 Million USD | 11208.836% |
| vTv Therapeutics Inc. | -20.25 Million USD | 4694.074% |
| Bio-Techne Corporation | 168.1 Million USD | -453.404% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 364.224% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | -621.986% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | 863.592% |
| Candel Therapeutics, Inc. | -37.93 Million USD | 2552.094% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | 925.891% |
| Nkarta, Inc. | -117.5 Million USD | 891.738% |
| BioCardia, Inc. | -11.57 Million USD | 8139.927% |
| Iterum Therapeutics plc | -38.37 Million USD | 2524.487% |